Dr. Juli Young, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1221 Eldon Way, Edgerton, WI 53534 Phone: 815-713-0096 |
Thomas H Reitz, D.D.S., S.C. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1007 N Main St, Edgerton, WI 53534 Phone: 608-884-3358 Fax: 608-884-4917 |
Dr. Jordan Leigh Davis, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 225 W Fulton St, Edgerton, WI 53534 Phone: 608-884-9448 |
News Archive
Why the U.S. Supreme Court continues to hold its oral arguments away from television cameras remains a mystery and national shame. The court is about to begin hearing six hours of arguments over three days in a lawsuit brought by more than half of the states in the nation to challenge the constitutionality of the Affordable Care Act, one of the most important pieces of economic legislation passed by Congress since the New Deal.
The House is considering a bill that would ban abortions in the District of Columbia after 20 weeks of pregnancy. Elsewhere, Missouri lawmakers consider allowing businesses to opt-out of a federal mandate to cover contraception in their health plans and another Catholic university - this one in Florida - considers dumping its health plan instead of complying with the mandate.
Pluristem Therapeutics, Inc. today announced the successful completion of a parallel scientific advisory process with the European Medical Agencies (EMA) and the U.S. Food and Drug Administration (FDA) regarding the Company's planned clinical development program for PLX-PAD.
Gamma Pharmaceuticals, Inc. announced the formation of a joint venture company with Jugular, Inc., replacing the brand licensing agreement in place between Gamma and Jugular since 2007. The new company, Gamma Jugular, LLC is closely integrated with Gamma's existing corporate infrastructure and distribution channels, and currently has three product lines and six SKUs with plans for expansion. Under the terms of the joint venture, Gamma will consolidate Gamma Jugular's performance into Gamma's financials.
New research supported by the National Institutes of Health delineates how two relatively common variations in a gene called KIF3A are responsible for an impaired skin barrier that allows increased water loss from the skin, promoting the development of atopic dermatitis, commonly known as eczema.
› Verified 8 days ago